MedPath

Rehabilitation of Taste and Smell Disorders Associated With Chemotherapy Using Aromatherapy

Not Applicable
Recruiting
Conditions
Cancer
Registration Number
NCT07041710
Lead Sponsor
Médipôle Lyon-Villeurbanne
Brief Summary

Changes in taste and smell can occur during chemotherapy treatment. These chemotherapy-related side effects can negatively impact patients' quality of life and diet.

The aim of this research is therefore to propose a solution to alleviate these taste and smell disorders. Based on the same principle as rehabilitation proposed for anosmia (loss of smell) related to COVID-19, we hypothesize that olfactory rehabilitation (using the sense of smell) through the odorous properties of essential oils could be effective for chemotherapy-related taste and smell alterations.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
104
Inclusion Criteria
  • cancer treated with chemotherapy
  • patient with taste and/or smell disorders
Exclusion Criteria
  • patient at the end of chemotherapy treatment

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
difference in scores between 6 months and the inclusion at "taste and smell disorders" questionnaire6 months

taste and smell disorders home-made questionnaire (score from 0 to 100)

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Médipôle Hôpital Mututaliste

🇫🇷

Villeurbanne, France

Médipôle Hôpital Mututaliste
🇫🇷Villeurbanne, France

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.